User:Mr. Ibrahem/Semaglutide

Semaglutide, sold under the brand names Ozempic among others, is a medication used to treat type 2 diabetes and obesity. It is less preferred to metformin, though they may be used together. It improves blood sugar control, decreases the risk of heart disease, and decreases the risk of kidney problems. It is used by mouth or by injection under the skin.

Common side effects including nausea, vomiting, diarrhea, abdominal pain, and constipation. Serious side effects may include diabetic ketoacidosis, low blood sugar, and pancreatitis. There are concerns that use during pregnancy may harm the baby and use when breastfeeding is not recommended. It works like human glucagon-like peptide-1 (GLP-1) and increases insulin release, decreases glucagon release, and slows stomach emptying.

Semaglutide was approved for medical use in the United States in 2017. It was developed by Novo Nordisk. It was the first GLP-1 that can be taken by mouth. In the United Kingdom 2 mg for injection costs the NHS about £73 as of 2020. This amount in the United States costs about 850 USD as of 2021.